This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
EV-302
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
mCRPC with Bone Metastasis
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Actionable Clinical Data
Kidney Cancer
ZIRCON
Trials in Progress
Trials in Progress
Bladder Cancer
BOND-003 Cohort P
CORE-008
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
ASCO GU 2025
SUO 2024
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Conference Highlights
ASCO 2020
ASCO 2020
Prostate Cancer
Bladder Cancer
Kidney Cancer
Testicular and Penile Cancer
Press Releases
ASCO 2020 Prostate Cancer
Viewing 21-40 of 71 articles
ASCO 2020: Morbidity Associated with Cancer Screening and Treatment: A Urologist Perspective
ASCO 2020: TALAPRO-2: a Placebo-Controlled Phase III Study of Talazoparib Plus Enzalutamide for Patients with First-Line Metastatic Castration-Resistant Prostate Cancer
ASCO 2020: A Phase 2 Randomized Trial of Radium-223 Dichloride and SABR vs. SABR for Oligometastatic Prostate Cancers (RAVENS)
ASCO 2020: Neoadjuvant Apalutamide plus Leuprolide with or Without Abiraterone in Localized High-Risk Prostate Cancer
ASCO 2020: Health-Related Quality of Life in PROfound for Olaparib vs Enzalutamide or Abiraterone in mCRPC with Homologous Recombination Repair Gene Alterations
ASCO 2020: Clinical, Genetic, and Pathologic Determinants of Prostate Cancer Brain Metastasis.
ASCO 2020: Contrasting Genomic Profiles in Post-Systemic Treatment Metastatic Sites, Pretreatment Primary Tumors and Liquid Biopsies of Clinically Advanced Prostate Cancer
ASCO 2020: Molecular Determinants of PSA Kinetics and Clinical Response to Apalutamide in Patients with nmCRPC in SPARTAN
ASCO 2020: TRANSFORMER: Bipolar Androgen Therapy vs Enzalutamide for Castration-Resistant Metastatic Prostate Cancer
ASCO 2020: The IP1-PROSTAGRAM Study: Population-Based Prostate Cancer Screening Using a Prospective, Blinded, Paired Screen-Positive Comparison of PSA and fast MRI
ASCO 2020: PROREPAIR-A: Clinical and Molecular Characterization Study of Prostate Cancer (PC) Patients with and Without Previously Known Germline BRCA1/2 Mutations
ASCO 2020: A Phase III Trial of Docetaxel versus Docetaxel and Radium-223 in Patients with mCRPC: DORA
ASCO 2020: Assessment and Management of Cardiovascular Risk Factors Among US Veterans with Prostate Cancer-Initiating Androgen Deprivation Therapy
ASCO 2020: Results from a Phase III, Prospective, Multicenter Study (CONDOR): Impact of PSMA-Targeted Imaging with 18F-DCFPyL-PET/CT on Clinical Management of Patients with Biochemically Recurrent Prostate Cancer
ASCO 2020: Prostate Cancer Relative Survival by Stage and Race/Ethnicity, United States, 2001 to 2015
ASCO 2020: The Comprehensive Methylation Landscape of mCRPC Identifies New Phenotypic Subtypes: Results from the West Coast Prostate Cancer Dream Team
ASCO 2020: LACOG 0415: Phase II Randomized Study of Abiraterone Acetate plus Prednisone Added to ADT Versus Apalutamide Alone vs AAP+APA in Patients with Advanced Prostate Cancer
ASCO 2020: Final Overall Survival from PROSPER: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Enzalutamide in Men with Nonmetastatic Castration-Resistant Prostate CancerĀ
ASCO 2020: Initial Experience of the Adjuvant Treatments to the Local Tumor for Metastatic Prostate Cancer: Assessment of Novel Treatment Algorithms, a Multicenter, Phase II Randomized Controlled Trial (IP2-ATLANTA)
ASCO 2020: First-in-Human Phase I Study of HPN424, a Tri-Specific Half-Life Extended PSMA-Targeting T-Cell Engager in Patients with mCRPC
1
2
3
4
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free